Skip to main content
. 2013 Jun 8;4:9–14. doi: 10.2147/LCTT.S45172

Table 6.

Objective response rate in patients administered daily gefitinib and alternate-day gefitinib following liver damage

Gefitinib 250 mg/day Reduced dose Total
RECIST
 CR 1 1 2
 PR 6 5 11
 SD 2 2 4
 PD 6 1 7
 CR + PR (%) 7 (46.7) 6 (66.7) 13 (54.2)

Abbreviations: RECIST, Response Evaluation Criteria in Solid Tumors; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.